Grant Detail
The grant detail shows the name of the PI, active dates of the project, the funding institute and the abstract of the grant. This abstract is what is used to create the fingerprint of the grant. If any publications referencing this grant are found in the data, they will be listed here as well.
Amyloid-beta: The Alternate Hypothesis
1 September 2005 - 31 August 2008
NATIONAL INSTITUTE ON AGING
Total Funding: $ 741,057
The "Amyloid Cascade Hypothesis" positing amyloid-ft (Aft) as a fundamental driving mechanism in disease pathogenesis is supported by numerous cellular, animal and human studies. However, an "Alternate Amyloid Hypothesis", positing Aft as an antioxidant that occurs secondary to oxidative stress, is an equally valid explanation for the wealth of in vitro and in vivo findings related to Aft. That the "Alternate Amyloid Hypothesis" and the "Amyloid Cascade Hypothesis" are essentially unchallenged by any currently available data is troubling from a scientific perspective and more so from a clinical perspective where current therapeutic efforts are targeted at the removal or limiting of Aft from the brain. The goal of our proposal is to conduct a series of experiments that should critically test both hypotheses to determine the role of Aft as pathogen or protectant. Specifically, we propose to use inducible transfected cell cultures together with state of the art molecular techniques to test the predominant hypothesis in the field. Our Specific Aims, guided by novel preliminary data are as follows: Aim 1) Determine whether pharmacologic inhibition of Aft with BACE inhibitors affects susceptibility to oxidative stress and whether this effect can be reversed ("rescued") by transfection with Aft1-40, Aft1-42, or C99; Aim 2) Determine whether mutations associated with familial Alzheimer disease are associated with alterations in oxidative stress and whether alterations in Aft production are affected by antioxidants or, vice versa, whether oxidative stress is altered by inhibition of Aft; Aim 3) Determine whether Aft is regulated by intracellular redox balance. Completion of the proposed studies will help determine the role of Aft and, more importantly, guide future therapeutic targets.
29 Resulting Publications
-
1.
2011D J Bonda; R J Castellani; X Zhu; A Nunomura; H-g Lee; G Perry; M A Smith
A novel perspective on tau in Alzheimer's disease.
Current Alzheimer research 2011;8(6):639-42. -
2.
2010Rudy J Castellani; Raj K Rolston; Mark A Smith
Disease-a-month : DM 2010;56(9):484-546. -
3.
2010Chris M Valdez; Mark A Smith; George Perry; Clyde F Phelix; Fidel Santamaria
Cholesterol homeostasis markers are localized to mouse hippocampal pyramidal and granule layers.
Hippocampus 2010;20(8):902-5. -
4.
2010Siddhartha Mondragón-Rodríguez; Gustavo Basurto-Islas; Hyoung-gon Lee; George Perry; Xiongwei Zhu; Rudy J Castellani; Mark A Smith
Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis.
Expert review of neurotherapeutics 2010;10(5):683-91. -
5.
2010Akihiko Nunomura; Toshio Tamaoki; Koich Tanaka; Nobutaka Motohashi; Masao Nakamura; Takaaki Hayashi; Haruyasu Yamaguchi; Shun Shimohama; Hyoung-gon Lee; Xiongwei Zhu; et al.
Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease.
Neurobiology of disease 2010;37(3):731-7. -
6.
2010Massimo Tabaton; Xiongwei Zhu; George Perry; Mark A Smith; Luca Giliberto
Signaling effect of amyloid-beta(42) on the processing of AbetaPP.
Experimental neurology 2010;221(1):18-25. -
7.
2010Katarzyna A Gustaw-Rothenberg; Sandra L Siedlak; David J Bonda; Alan Lerner; Massimo Tabaton; George Perry; Mark A Smith
Experimental gerontology 2010;45(1):47-52. -
8.
2010Paula I Moreira; Xiongwei Zhu; Xinglong Wang; Hyoung-Gon Lee; Akihiko Nunomura; Robert B Petersen; George Perry; Mark A Smith
Mitochondria: a therapeutic target in neurodegeneration.
Biochimica et biophysica acta 2010;1802(1):212-20. -
9.
2010Mark A Smith; Xiongwei Zhu; Massimo Tabaton; Gang Liu; Daniel W McKeel; Mark L Cohen; Xinglong Wang; Sandra L Siedlak; Barney E Dwyer; Takaaki Hayashi; et al.
Journal of Alzheimer's disease : JAD 2010;19(1):363-72. -
10.
2010David J Bonda; Maneesh Mailankot; Jeremy G Stone; Matthew R Garrett; Magdalena Staniszewska; Rudy J Castellani; Sandra L Siedlak; Xiongwei Zhu; Hyoung-gon Lee; George Perry; et al.
Redox report : communications in free radical research 2010;15(4):161-8. -
11.
2009Hyun-Pil Lee; Gemma Casadesus; Xiongwei Zhu; Hyoung-gon Lee; George Perry; Mark A Smith; Katarzyna Gustaw-Rothenberg; Alan Lerner
All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease.
Expert review of neurotherapeutics 2009;9(11):1615-21. -
12.
2009Barney E Dwyer; Meghan L Stone; Nadia Gorman; Peter R Sinclair; George Perry; Mark A Smith; Xiongwei Zhu
Heme-a, the heme prosthetic group of cytochrome c oxidase, is increased in Alzheimer's disease.
Neuroscience letters 2009;461(3):302-5. -
13.
2009Barney E Dwyer; Mark A Smith; Sandy L Richardson; George Perry; Xiongwei Zhu
Neuroscience letters 2009;460(2):180-4. -
14.
2009Gang Liu; Ping Men; Wataru Kudo; George Perry; Mark A Smith
Neuroscience letters 2009;455(3):187-90. -
15.
2009Barney E Dwyer; Leo R Zacharski; Dominic J Balestra; Alan J Lerner; George Perry; Xiongwei Zhu; Mark A Smith
Getting the iron out: phlebotomy for Alzheimer's disease?
Medical hypotheses 2009;72(5):504-9. -
16.
2009Hyun-Pil Lee; Xiaochun Zhu; Xiongwei Zhu; S Chad Skidmore; George Perry; Lawrence M Sayre; Mark A Smith; Hyoung-Gon Lee
Journal of neurochemistry 2009;108(6):1434-41. -
17.
2009Sandra L Siedlak; Gemma Casadesus; Kate M Webber; Miguel A Pappolla; Craig S Atwood; Mark A Smith; George Perry
Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease.
Free radical research 2009;43(2):156-64. -
18.
2009V Prakash Reddy; Xiongwei Zhu; George Perry; Mark A Smith
Oxidative stress in diabetes and Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2009;16(4):763-74. -
19.
2009Rudy J Castellani; Hyoung-gon Lee; Sandra L Siedlak; Akihiko Nunomura; Takaaki Hayashi; Masao Nakamura; Xiongwei Zhu; George Perry; Mark A Smith
Journal of Alzheimer's disease : JAD 2009;18(2):447-52. -
20.
2009Gang Liu; Ping Men; George Perry; Mark A Smith
Progress in brain research 2009;180():97-108. -
21.
2008Michael W Marlatt; Paul J Lucassen; George Perry; Mark A Smith; Xiongwei Zhu
Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies.
Journal of Alzheimer's disease : JAD 2008;15(2):199-210. -
22.
2008Katarzyna A Gustaw; Matthew R Garrett; Hyoung-Gon Lee; Rudy J Castellani; Michael G Zagorski; Annamalai Prakasam; Sandra L Siedlak; Xiongwei Zhu; George Perry; Robert B Petersen; et al.
Antigen-antibody dissociation in Alzheimer disease: a novel approach to diagnosis.
Journal of neurochemistry 2008;106(3):1350-6. -
23.
2008Rudy J Castellani; Akihiko Nunomura; Hyoung-gon Lee; George Perry; Mark A Smith
Phosphorylated tau: toxic, protective, or none of the above.
Journal of Alzheimer's disease : JAD 2008;14(4):377-83. -
24.
2008Rudy J Castellani; Hyoung-Gon Lee; Xiongwei Zhu; George Perry; Mark A Smith
Alzheimer disease pathology as a host response.
Journal of neuropathology and experimental neurology 2008;67(6):523-31. -
25.
2008Siddhartha Mondragón-Rodríguez; Gustavo Basurto-Islas; Ismael Santa-Maria; Raúl Mena; Lester I Binder; Jesús Avila; Mark A Smith; George Perry; Francisco García-Sierra
International journal of experimental pathology 2008;89(2):81-90. -
26.
2007Xinglong Wang; Bo Su; George Perry; Mark A Smith; Xiongwei Zhu
Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease.
Free radical biology & medicine 2007;43(12):1569-73. -
27.
2007Hyoung-gon Lee; Xiongwei Zhu; Rudy J Castellani; Akihiko Nunomura; George Perry; Mark A Smith
Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses.
The Journal of pharmacology and experimental therapeutics 2007;321(3):823-9. -
28.
2007Robert B Petersen; Akihiko Nunomura; Hyoung-gon Lee; Gemma Casadesus; George Perry; Mark A Smith; Xiongwei Zhu
Signal transduction cascades associated with oxidative stress in Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2007;11(2):143-52. -
29.
2006Hyoung-gon Lee; Xiongwei Zhu; George Perry; Mark A Smith
The fallacy of amyloid and cognition in Alzheimer's disease.
Drugs & aging 2006;23(2):179.
Scientific Context
This section shows information that has been computed by using the fingerprint of the grant, including related publications, related experts and related grants - all with fingerprints representing significant amounts of overlap between their fingerprint and this grant. The red dots indicate whether those experts or terms actually appear within this grant, showing potential and actual connections.
Related Grants
-
1.
Bush, Ashley I
BRAIN METAL INTERACTIONS IN ALZHEIMER'S DISEASE
1 May 1994 - 31 August 2007
NATIONAL INSTITUTE ON AGING
Total Funding: $ 1,215,118
-
2.
Cole, Gregory M
Can Omega 3 fatty acids Slow Alzheimer Pathogensis?
1 September 2005 - 31 August 2009
NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE
Total Funding: $ 1,072,290
-
3.
COTMAN, CARL W
MECHANISMS AND MOLECULAR PROFILES OF DEGENERATION IN AD
25 May 1995 - 30 April 2001
NATIONAL INSTITUTE ON AGING
Total Funding: $ 1,154,804
Related Publications
-
1.
2006Rukhsana Sultana; Shelley F Newman; Hafiz Mohmmad Abdul; Jian Cai; William M Pierce; Jon B Klein; Michael Merchant; D Allan Butterfield
Journal of neuroscience research 2006;84(2):409-17. -
2.
2004M Flint Beal
Journal of bioenergetics and biomembranes 2004;36(4):381-6. -
3.
2001W Deuther-Conrad; C Loske; R Schinzel; R Dringen; P Riederer; G Münch
Neuroscience letters 2001;312(1):29-32.
Related Topics
Appears in this Publication
Related Experts
Author of this Publication
-
Internal ExpertsPublications
-
540









-
610









-
439









-
411









-
206









-
252











